Tecan has developed the Freedom EVOware Normalization Wizard, specifically for normalization applications in genomic, forensic, protein science and drug discovery laboratories. This new feature, which offers solutions for high quality nucleic acid preparation, including PCR set-up, reaction clean-up, sample quantitation and normalization, is the latest example of Freedom EVOware's great range of flexibility for system customization.
First, a Quantitation Wizard determines the concentrations of samples, in conjunction with Tecan microplate readers and Magellan(TM) software. Then, by automatically generating a pipetting script for easy automation of sample quantitation and normalization, the software brings all the samples to a uniform concentration on a single microplate. The Normalization Wizard can import data directly from the Quantitation Wizard, or from data files of third party devices such as real-time PCR instrumentation, as well as those generated by LIMS.
Tecan's Freedom EVOÂ® automated workstations, together with Freedom EVOware, are capable of all pipetting and microplate handling steps in sample normalization. Data transformations are completed during script runtime without the need for user interaction, enabling a fully automated walk-away system.
Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor: 1210019).
For further information please contact:
Tecan Switzerland AG
T +41 44 922 81 11
F +41 44 922 81 12